Reemergence of Sylvatic Dengue Virus Serotype 2 in Kedougou, Senegal, 2020
Idrissa Dieng
1, Maryam Diarra
1, Bacary Djilocalisse Sadio, Bocar Sow, Alioune Gaye, Amadou Diallo, Martin Faye, Marie Henriette Dior Ndione, Diawo Diallo, Safietou Sankhe, Mignane Ndiaye, Fode Danfakha, Boly Diop, Amadou Alpha Sall, Gamou Fall, Oumar Faye, Cheikh Loucoubar, Ousmane Faye, Scott C. Weaver, Mawlouth Diallo, Mamadou Aliou Barry
1, and Moussa Moise Diagne
1
Author affiliations: Institut Pasteur de Dakar, Dakar, Senegal (I. Dieng, M. Diarra, B.D. Sadio, B. Sow, A. Gaye, A. Diallo, M. Faye, M.H.D. Ndione, D. Diallo, S. Sankhe, M. Ndiaye, A.A. Sall, G. Fall, Oumar Faye, C. Loucoubar, Ousmane Faye, M. Diallo, M.A. Barry, M.M. Diagne); Ministry of Health Kedougou Medical Region, Kedougou, Senegal (F. Danfakha); Ministry of Health Prevention Department, Dakar (B. Diop); University of Texas Medical Branch, Galveston, Texas, USA (S.C. Weaver)
Main Article
Figure 1
Figure 1. Distribution of reported cases within 4 healthcare centers during the sylvatic dengue outbreak in Kedougou region, Senegal, during November 2020–February 2021. Inset shows the Kedougou region in the southeastern corner of Senegal. Patient samples were positive according to qRT-PCR or dengue virus IgM assays of serum samples. Numbers in squares indicate the number of negative and positive cases. qRT-PCR, quantitative reverse transcription PCR.
Main Article
Page created: February 08, 2024
Page updated: March 20, 2024
Page reviewed: March 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.